- Home
- CGBD vs KURA Comparison
CGBD vs KURA Comparison
Compare CGBD & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGBD | KURA |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.2M | 1.0B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGBD | KURA |
|---|---|---|
| Price | $12.50 | $10.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 11 |
| Target Price | $13.70 | ★ $25.00 |
| AVG Volume (30 Days) | 519.9K | ★ 1.7M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | ★ 12.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $245,008,000.00 | $104,029,000.00 |
| Revenue This Year | $13.53 | $138.16 |
| Revenue Next Year | $4.24 | $66.98 |
| P/E Ratio | $11.17 | ★ N/A |
| Revenue Growth | ★ 2.55 | N/A |
| 52 Week Low | $11.55 | $5.41 |
| 52 Week High | $18.64 | $12.49 |
Technical Indicators
Market Signals| Indicator | CGBD | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 46.43 |
| Support Level | $12.44 | $9.68 |
| Resistance Level | $12.79 | $11.28 |
| Average True Range (ATR) | 0.22 | 0.49 |
| MACD | -0.04 | -0.05 |
| Stochastic Oscillator | 25.73 | 42.50 |
Price Performance
Historical ComparisonAbout CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.